AVAPS Explained: A Vital Tool for Hypoventilation Syndrome Management

Authored by Terrence Shenfield, MS, RRT-ACCS, RPFT, NPS, AE-C

Managing respiratory failure, both acute and chronic, is a primary focus in critical and home care settings. Conditions that lead to hypoventilation, such as Obesity Hypoventilation Syndrome (OHS), Chronic Obstructive Pulmonary Disease (COPD), and certain neuromuscular diseases, present significant challenges for clinicians. The primary goal is to ensure adequate ventilation, reduce the work of breathing, and improve gas exchange. While Bilevel Positive Airway Pressure (BiPAP) has long been a standard for non-invasive ventilation (NIV), newer, more intelligent modes have emerged. Average Volume-Assured Pressure Support (AVAPS) is one such innovation, offering a more sophisticated approach to managing hypoventilation syndromes.

This comprehensive guide will explore the intricacies of the AVAPS Mode, explain its function, and detail why it is often a superior choice for patients with hypoventilation. We will delve into the BIPAP vs AVAPS debate, examine typical AVAPS settings, and highlight the clinical benefits that make an AVAP machine an indispensable tool in modern respiratory care. By understanding this technology, respiratory therapists and clinicians can enhance patient outcomes and improve the quality of life for those struggling with chronic respiratory insufficiency.

Understanding Hypoventilation and the Need for Advanced Support

Hypoventilation occurs when breathing is too slow or too shallow to meet the body's metabolic needs, leading to an increase in arterial carbon dioxide (PaCO2) levels, a condition known as hypercapnia. Chronic hypercapnia can cause a range of symptoms, from morning headaches and daytime sleepiness to severe respiratory acidosis and right-sided heart failure.

Several conditions predispose patients to hypoventilation:

• Obesity Hypoventilation Syndrome (OHS): Defined by the triad of obesity (BMI >30 kg/m²), daytime hypercapnia (PaCO2 >45 mmHg), and sleep-disordered breathing, OHS is a growing concern.
• COPD: Severe COPD can lead to respiratory muscle fatigue and an inability to maintain adequate minute ventilation, resulting in CO2 retention.
• Neuromuscular Diseases: Conditions like Amyotrophic Lateral Sclerosis (ALS) and muscular dystrophy weaken respiratory muscles, impairing ventilatory capacity.
• Chest Wall Deformities: Severe kyphoscoliosis can restrict lung expansion and lead to chronic respiratory failure.

Traditional non-invasive ventilation, like BiPAP in Spontaneous/Timed (S/T) mode, delivers a fixed inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). While effective for many, this approach has limitations. A patient's respiratory needs can change throughout the night due to shifts in sleep stages, body position, or varying respiratory mechanics. With a fixed pressure, the delivered tidal volume (the amount of air moved in and out of the lungs with each breath) can fluctuate, potentially leading to periods of hypoventilation. This is where AVAPS technology offers a significant advantage.

What is AVAPS Mode and How Does It Work?

Average Volume-Assured Pressure Support (AVAPS) is an advanced mode of non-invasive ventilation that combines the benefits of both pressure support and volume-targeted ventilation. Instead of setting a fixed IPAP, the clinician sets a target tidal volume (VT). The AVAP machine then automatically adjusts the amount of pressure support (the difference between IPAP and EPAP) on a breath-by-breath basis to ensure the average target tidal volume is delivered over a specific period, typically one minute.

Here’s a breakdown of its mechanism:

1. Target Tidal Volume: The primary setting is the desired tidal volume, usually calculated based on the patient's ideal body weight (e.g., 6-8 mL/kg).
2. Pressure Range: The clinician sets a minimum and maximum IPAP range (IPAP Min and IPAP Max). This creates a safe operational window for the ventilator.
3. Automatic Adjustments: The ventilator continuously monitors the patient's delivered tidal volume. If the volume falls below the target, the machine gradually increases the IPAP on subsequent breaths to provide more support. Conversely, if the delivered volume exceeds the target, it reduces the IPAP.
4. Gradual Changes: These pressure adjustments occur slowly and smoothly, preventing abrupt changes that could disrupt the patient's sleep or cause discomfort. The algorithm is designed to make incremental changes, often no more than 1-2.5 cmH2O per minute, to reach the target volume.

This intelligent feedback loop ensures that the patient consistently receives the necessary level of ventilation to maintain alveolar ventilation and control PaCO2 levels, even as their own respiratory effort or lung compliance changes. For those looking to master these advanced modalities, a dedicated webinar can provide invaluable hands-on insights and training.

Key Differences: BIPAP vs AVAPS

The fundamental distinction in the BIPAP vs AVAPS comparison lies in what the ventilator targets. Standard BiPAP is a pressure-targeted mode, whereas AVAPS is a volume-targeted hybrid mode.

Feature	Standard BiPAP (S/T Mode)	AVAPS Mode
Primary Goal	Maintain a set pressure	Maintain a target tidal volume
IPAP Setting	Fixed IPAP set by the clinician	Variable IPAP that adjusts automatically within a set range
Tidal Volume	Variable; depends on patient effort and lung mechanics	Consistent; averaged over time to meet the set target
Adaptability	Limited; does not automatically adjust to changing needs	High; adapts to changes in sleep stage, body position, and respiratory mechanics
Work of Breathing	Can increase if patient needs more support than the set IPAP provides	Automatically adjusts to unload respiratory muscles and maintain ventilation
Patient-Ventilator Synchrony	Can be compromised if patient's needs fluctuate	Often improved due to gradual pressure adjustments

For patients with hypoventilation, whose primary issue is insufficient tidal volume, the AVAPS approach is inherently more logical. It directly addresses the physiological problem by guaranteeing a minimum level of ventilation. Standard BiPAP, by only guaranteeing pressure, leaves the crucial factor of tidal volume to chance, which can be unreliable in patients with fluctuating respiratory drive or mechanics.

Setting Up an AVAP Machine: A Guide to AVAPS Settings

Properly configuring AVAPS settings is crucial for therapeutic success. While specific parameters depend on the individual patient's condition and institutional protocols, here is a general guideline for initiating AVAPS therapy:

• Target Tidal Volume (VT): Set at 6-8 mL/kg of ideal body weight. It's often best to start at the lower end and titrate up based on clinical response and patient comfort.
• Expiratory Positive Airway Pressure (EPAP): Typically set between 5-8 cmH2O. The goal is to prevent upper airway collapse, especially in patients with coexisting obstructive sleep apnea (OSA), and to improve oxygenation.
• Minimum IPAP (IPAP Min): This is the lowest pressure the ventilator will deliver. It is usually set at EPAP + 4 cmH2O, but no less than 8 cmH2O total, to ensure a baseline level of pressure support.
• Maximum IPAP (IPAP Max): This sets the upper limit for pressure delivery, acting as a safety ceiling. It is commonly set between 20-25 cmH2O to minimize the risk of gastric insufflation and barotrauma. Some newer devices may allow for higher pressures.
• Respiratory Rate (RR) / Backup Rate: Set 2-3 breaths per minute below the patient's resting respiratory rate. This ensures the ventilator will deliver a timed breath if the patient becomes apneic or their spontaneous rate drops too low.
• Inspiratory Time (I-Time): Typically set between 0.8 and 1.2 seconds, depending on the respiratory rate and desired I:E ratio.
• Rise Time: This setting controls how quickly the ventilator reaches the target IPAP. A slower rise time can improve comfort for some patients.

After initiation, clinicians should closely monitor the patient for comfort, mask leak, and patient-ventilator synchrony. Arterial blood gas (ABG) analysis or transcutaneous CO2 monitoring is essential to confirm that the settings are effectively correcting hypercapnia. As the patient’s condition improves or changes, these settings may require further adjustment.

The Clinical Advantages of AVAPS for Hypoventilation Syndromes

The theoretical benefits of the AVAPS Mode translate into tangible clinical advantages for patients with hypoventilation. Research and clinical practice have demonstrated its effectiveness across various patient populations.

1. Guaranteed Minute Ventilation and Stable CO2 Control

The primary benefit of AVAPS is its ability to ensure a consistent tidal volume, leading to stable minute ventilation. This is particularly crucial during sleep, when respiratory drive naturally decreases, especially during REM sleep. A 2022 study published in The Egyptian Journal of Chest Diseases and Tuberculosis evaluated AVAPS in patients with OHS. The results showed that AVAPS provided an earlier and more significant decrease in PaCO2 levels compared to conventional BiPAP. The mode's ability to maintain ventilation regardless of sleep stage or patient effort leads to more effective and reliable correction of daytime hypercapnia.

2. Improved Patient Comfort and Adherence

Adherence to NIV therapy is a major determinant of its success. Discomfort from high fixed pressures is a common reason for non-adherence with standard BiPAP. The AVAP machine addresses this by starting at a lower pressure (IPAP Min) and only increasing it as needed. This "as-needed" support is often perceived as more comfortable by patients. The same 2022 study noted that the AVAPS group experienced lower leak volumes, suggesting better tolerability and interface fit. By improving comfort, AVAPS can significantly enhance long-term adherence, which is critical for managing chronic respiratory failure.

3. Automatic Titration and Reduced Clinician Workload

In a busy clinical environment, AVAPS offers a degree of automated titration. Once the initial AVAPS settings are in place, the machine handles the fine-tuning of pressure support to meet the volume target. This can simplify the management of complex patients and may reduce the need for frequent manual adjustments that are often required with standard BiPAP. While it does not replace the need for skilled clinical oversight, it streamlines the process of optimizing ventilation. For professionals seeking to expand their knowledge on this and other topics, a wide array of online education category courses are available.

4. Versatility Across Different Conditions

AVAPS has proven effective in a variety of conditions characterized by hypoventilation.

• Obesity Hypoventilation Syndrome (OHS): As mentioned, AVAPS is highly effective in OHS by ensuring adequate tidal volume despite increased chest wall impedance from excess weight.
• COPD with Hypercapnia: In stable hypercapnic COPD patients, AVAPS can improve gas exchange, sleep quality, and health-related quality of life more effectively than fixed-pressure NIV.
• Neuromuscular Disease: For patients with progressive muscle weakness, AVAPS can adapt to their declining respiratory function over time, automatically increasing pressure support as their own strength wanes. This provides consistent support and can delay the need for invasive ventilation.

Mastering these applications is key for respiratory therapists. For further professional development, consider enrolling in a specialized webinar focused on advanced non-invasive ventilation strategies.

When Is BiPAP Still a Viable Option?

Despite the clear advantages of AVAPS for hypoventilation, standard BiPAP S/T mode is not obsolete. It remains a cost-effective and appropriate choice for many patients, particularly those with less complex needs.

• Obstructive Sleep Apnea: For patients whose primary issue is upper airway obstruction without significant underlying hypoventilation, standard BiPAP is often sufficient to stent the airway open.
• Acute Hypoxemic Respiratory Failure: In conditions where the primary goal is to improve oxygenation and reduce the work of breathing (e.g., cardiogenic pulmonary edema), the pressure support provided by BiPAP can be highly effective. In these cases, guaranteeing a specific tidal volume may be less critical than providing positive pressure to recruit alveoli and improve oxygenation.
• Resource Constraints: Standard BiPAP machines are generally less expensive and more widely available than devices with AVAPS capability. In settings with limited resources, BiPAP remains a workhorse of non-invasive support.

However, a 2022 study in Critical Care Research and Practice comparing BiPAP S/T-AVAPS to BiPAP S/T alone in patients with de novo hypoxemic respiratory failure found no superiority of the AVAPS mode. This underscores that the choice of mode should be tailored to the underlying pathophysiology. For hypoventilation, AVAPS is targeted therapy; for hypoxemia, the benefits are less clear.

Conclusion: Elevating the Standard of Care for Hypoventilation

The management of hypoventilation syndromes requires a nuanced approach that prioritizes consistent and adequate ventilation. While standard BiPAP has served patients well for decades, the introduction of the AVAPS Mode represents a significant leap forward. By targeting tidal volume instead of just pressure, an AVAP machine provides a more intelligent, adaptable, and reliable form of support for patients with OHS, COPD, and neuromuscular disorders.

The BIPAP vs AVAPS discussion ultimately hinges on the patient's specific condition. For chronic hypercapnic respiratory failure, the evidence points toward AVAPS as a superior option for ensuring stable ventilation, improving adherence, and achieving better clinical outcomes. Its ability to automatically adjust support in response to changing patient needs makes it a powerful tool for clinicians and a more comfortable therapy for patients.

As respiratory care continues to evolve, embracing advanced technologies like AVAPS is essential for providing the highest standard of care. By investing in continuous learning through resources like our comprehensive online education category, respiratory therapists can master these advanced modes and make a profound difference in the lives of patients with chronic respiratory insufficiency.

Citations

1. Acet Öztürk, N., Güçlü, Ö. A., Demirdöğen, E., Dilektaşlı, A. G., Maharramov, S., Coşkun, F., Uzaslan, E., Ursavaş, A., & Karadağ, M. (2022). AVAPS-NIV Treatment in Hypercapnic Respiratory Failure with Insufficient Response to Fixed-Level PS-NIV. Tüberküloz ve toraks, 70(4), 324–333.
2. Briones-Claudett, K. H., Briones-Claudett, M. H., Cabrera Baños, M. D. P., Briones Zamora, K. H., Briones Marquez, D. C., Zimmermann, L. J. I., Gavilanes, A. W. D., & Grunauer, M. (2022). Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support versus BiPAP S/T in De Novo Hypoxemic Respiratory Failure. Critical Care Research and Practice, 2022, 4333345.
3. El Maksude, H. A. A., ElSharawy, D. E., Ahmed, L. M. S., & Elkholy, M. G. A. (2022). Impact of average volume-assured pressure-support mode on the management of obesity hypoventilation syndrome. The Egyptian Journal of Chest Diseases and Tuberculosis, 71(3), 325–329.
4. Maheshwari, A., Khatri, J., Soni, G., & Saini, N. (2022). Role of Average Volume Assured Pressure Support Mode (AVAPS) in the Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Type 2 Respiratory Failure. Cureus, 14(12), e32200.
5. Yarrarapu, S. N. S., Saunders, H., & Sanghavi, D. K. (2023). Average Volume-Assured Pressure Support. In StatPearls. StatPearls Publishing.